9th Annual Biomarkers Congress

Cancer Biology: University of Toronto

Total Score People Score Events Score
56 42 36
Date Event Presentation Speakers
November 14, 2013 2013 PQG Conference - Emerging Quantitative Issues in Disease Epigenetics PANEL DISCUSSION Mathieu Lupien
June 12, 2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Peter B Dirks, Annie Huang, James Perry, Michael Taylor, Gelareh Zadeh
April 6, 2013 AACR Annual Meetings The Bayard D. Clarkson Symposium on Stem Cells and Cancer: Stem Cell Biology and Therapeutics John E. Dick
Nanotechnology Approaches to the Treatment of Cancer Warren Chan
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Jinrong Min
January 20, 2013 Tumor Invasion and Metastasis Models of postsurgical early and late stage metastasis for improving preclinical adjuvant and metastatic therapy investigations Robert S Kerbel
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Overcoming Stem Cell Tourism by Promoting Clinical Trials Armand Keating
Regenerative Medicine Armand Keating
Clinical Oncology Update: Studies from the 2012 ASCO Annual Meeting Armand Keating
April 15, 2012 28th IABCR/Breakthrough Breast Cancer Conference Mammary gland involution drives breast cancer progression through collagen and COX-2 Norman F Boyd
September 11, 2011 Stem Cells in Development and Disease Stem Cells in Development and Disease John E. Dick, Janet Rossant
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease BMPs in neuronal morphogenesis Liliana Attisano
July 6, 2011 3rd WIN Symposium Improving the prospects of preclinical models to predict investigational drug efficacy in the clinic and clinical trials Robert S Kerbel
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis Recent issues emerging from the use of antiangiogenic drugs in the clinic Robert S Kerbel
March 25, 2011 Eighth International Symposium on Ovarian Cancer and Gynecologic Malignancies CON Allan Covens
PRO Allan Covens
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Stem Cells in Leukemia: Do They Matter? John E. Dick
March 3, 2011 Stem Cells, Development, and Cancer Engineering cell fate analysis for cell and molecular therapy development Peter W Zandstra
Defining similarities and differences between normal neural stem cells and brain tumor stem cells Peter B Dirks
February 27, 2011 Signal Transduction within the Nucleus Gordon Research Conference Using yeast functional genomics to map transcriptional regulatory networks and pathways Brenda Andrews
October 24, 2010 Frontiers in Tumour Progression Three Short Talks Robert S. Kerbel
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Taking Low-Dose Metronomic Chemotherapy from a Preclinical Concept to a Promising Clinical Treatment for Metastatic Disease Robert S. Kerbel
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Preclinical modelling of adjuvant and metastatic antiangiogenic therapies Robert S. Kerbel
June 14, 2010 Development and Stem Cells in the Pancreas Gene-environment interactions in Type 1 diabetes Jayne Danska
May 19, 2010 Towards Personalized Cancer Medicine Next-Generation Sequencing Technologies John McPherson
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Research Overview Dugald Seely
October 13, 2009 Fourth Annual Drug Repositioning Summit Identification of FDA-Approved Drugs with New Activity Against Leukemia Aaron D. Schimmer
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Synthetic PDZ Domains for Functional Genomics Sachdev Sidhu
Antibody Fragments and Scaffolds Sachdev Sidhu
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Chemical genomic tools to understand drug action and gene function Guri Giaever
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) The Development of Broad Spectrum Antiviral Drugs: A New Strategy :Track 2-3 Eleanor N Fish
Mechanisms that Explain the Lower Incidence of Breast Cancer in Postmenopausal Women Treated with Conjugated Equine Estrogens. Role of Estrogen Receptor Alpha and Beta :Track 2-4 (II) Bhagu Bhavnani
An Important Diabetes Susceptibility Gene, Namely TCF 7L 2 :Track 2-8 Tianru Jin
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Split Session A: Folate, DNA Methylation and Cancer Prevention Young-In J. Kim
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Relevance of In Vitro and In Vivo Models to Idiosyncratic Reactions in the Skin Jack Uetrecht
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- Endocrine Therapy of Breast Cancer in the Adjuvant Setting Kathy I. Pritchard
breast cancer-- Endocrine Therapy of Breast Cancer in the Adjuvant Setting Kathy I. Pritchard
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Robert S. Kerbel
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Robert S. Kerbel
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Translating Metronomic Antiangiogenic Chemotherapy into the Clinic for Advanced Metastatic Cancer Robert S. Kerbel
January 18, 2008 Translational Research Program Stem Cell Symposium Panel Discussion Dick P Richard Hill
December 13, 2007 Stem Cells 2007 Session: Epithelial cancers John E. Dick
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management Welcome from UHN Robert Bell
How a targeted antiangiogenic drug may amplify the efficacy of conventional chemotherapy Robert S. Kerbel
Session IV: Medical Imaging and Intervention Martin E. O’Malley
Role of PET in the management of malignant disease Marc Freeman
Radiofrequency ablation of tumors: Current status John R. Kachura
Session V: Genitourinary Neil Fleshner
Future of targeted therapy in cancer Tak Mak
Can we target triple negative breast cancer? Rebecca Dent
Choosing adjuvant therapy in the molecular era Kathy I. Pritchard
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 13: (Part One) Development of Novel Drug Delivery Systems (Part Two) Combinatorial Chemistry & High Throughput Screening (09:00-12:00) Gang Zheng
Session 13: (Part One):Lipoprotein-like Nanocarriers for In Vivo Cancer Imaging and Treatment (09:20-09:40) Gang Zheng
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Structural Variation Analysis (08:30-10:30) Lars Feuk
Structural Variation Analysis: High-Resolution Analysis of Structural Variation in the Human Genome (08:35-09:05) Lars Feuk
October 17, 2007 The Second International Symposium on Hereditary Breast and Ovarian Cancer Comparing regional, national and international patterns of preventive choices for women with BRCA1/2 mutation carriers Kelly Metcalfe
October 1, 2007 Barcelona BioMed Conferences: STEM CELLS AND CANCER Session IV: Cancer stem cells - I (14:30-18:20) John E. Dick, Peter B Dirks
Session IV: Cancer stem cells - I (14:30-15:05) John E. Dick
Session IV: Cancer stem cells - I (15:05 -15:40) Peter B Dirks
July 14, 2007 BIOLOGY OF CALPAINS IN HEALTH AND DISEASE Structure of calpain 9 protease core Sirano Dhe Paganon
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.